Koyfin Home > Directory > Health Care > Boston Scientific Corp > Total Debt / (EBITDA-CAPEX)

Boston Scientific Corp Total Debt / (EBITDA-CAPEX) Chart (BSX)

Boston Scientific Corp annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Boston Scientific Corp Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $13m a 61.35% increase of 8m year over year
  • Boston Scientific Corp Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $5m a 13.64% increase of 1m year over year
  • Boston Scientific Corp Annual Total Debt / (EBITDA-CAPEX) for 2019 was $4m a 27.41% increase of 1m from 2018
  • Boston Scientific Corp Annual Total Debt / (EBITDA-CAPEX) for 2018 was $3m a 14.27% increase of 0m from 2017
  • Boston Scientific Corp Annual Total Debt / (EBITDA-CAPEX) for 2017 was $3m a -13.34% decrease of 0m from 2016
Other Ratios Metrics:
  • Boston Scientific Corp Total Debt / Capital for the quarter ending December 12, 2018 was $44m a -1.42% decrease of -1m year over year
  • Boston Scientific Corp Other Liabilities for the quarter ending September 09, 2018 was $2,202m a -16.30% decrease of -359m year over year
  • Boston Scientific Corp Total Debt / Equity for the quarter ending December 12, 2018 was $80m a -2.59% decrease of -2m year over year
View Chart On Koyfin

Quarterly BSX Total Debt / (EBITDA-CAPEX) Data

06/2020$13m
03/2020$6m
12/2019$4m
09/2019$5m
06/2019$4m
03/2019$4m
12/2018$3m
09/2018$3m
06/2018$3m
03/2018$3m

Annual BSX Total Debt / (EBITDA-CAPEX) Data

2019$4m
2018$3m
2017$3m
2016$3m
2015$4m
2014$3m
2013$3m
2012$3m
2011$3m
2010$3m